2020
DOI: 10.1097/upj.0000000000000128
|View full text |Cite
|
Sign up to set email alerts
|

Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…While new technologies are being developed to treat OAB syndrome, we would like to focus on novel small implanted devices that stimulate the tibial nerve, providing physicians and patients with more treatment options when conservative measures fail to relieve symptoms [ 54 ]. This study will summarize different implant types and their efficacy and safety.…”
Section: Posterior Tibial Nerve Stimulation Classificationsmentioning
confidence: 99%
See 1 more Smart Citation
“…While new technologies are being developed to treat OAB syndrome, we would like to focus on novel small implanted devices that stimulate the tibial nerve, providing physicians and patients with more treatment options when conservative measures fail to relieve symptoms [ 54 ]. This study will summarize different implant types and their efficacy and safety.…”
Section: Posterior Tibial Nerve Stimulation Classificationsmentioning
confidence: 99%
“…The primary advantage of this technology is that it allows patients to receive treatment overnight, but electrode migration could be a significant issue [ 65 ]. Currently, a study is being undertaken to compare StimGuard CAN-stim against Medtronic InterStim [ 35 , 54 , 56 , 57 , 63 ].…”
Section: Posterior Tibial Nerve Stimulation Classificationsmentioning
confidence: 99%
“…The maintenance-free, fully implantable eCoin device has unique attributes compared to current OAB treatments, including delivery with a brief procedure using only local anesthetic and reliance on minimal resources. 18,19 Other potential benefits include automated compliance and less precision of placement compared to both SNM surgery and chronic PTNS sessions with possible elimination of intermittent onabotulinumtoxinA intradetrusor injections. 20 Thus, the aim of this study was to assess the efficacy and safety of eCoin for treatment of OAB with UUI, which might better manage these patients given the distinct features of this novel form factor.…”
mentioning
confidence: 99%